Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for ArQule, Inc. (ARQL)

« Back to company index

ARQL Chatter Timeline

Stock Ticker for ARQL

Most Active Tweeters for ARQL

UserTweets
@FinanceBubble 1

Recent Tweets for ARQL

FinanceBubble @FinanceBubble
$APTO should build from here going into December with data on their BTK Inhibitor. Looks up $ARQL - this may easi… https://t.co/3v32Qt9dXE
October 23rd 2020, 12:10pm
BertrandBio @BertrandBio
@gcbioinv I thought about your good move on $ARQL when I saw his name last week on Mereo's PR :) Can't be a bad thing, I said to myself.
October 9th 2020, 4:10pm
gcbioinv @gcbioinv
One of my favorite C-suite folks to talk to over the years, Brian Schwartz of $ARQL, joined $MREO's board. Also on… https://t.co/DtO70FVhIc
October 9th 2020, 4:10pm
Varro_Analytics @Varro_Analytics
@gcbioinv @MSollender How many at one time? Big companies are far more complex than $ARQL (which you surely nailed… https://t.co/DUVXmR7buR
October 8th 2020, 11:10pm
jrock452 @jrock452
$APTO = $ARQL part 2
October 1st 2020, 1:10pm
fierro7676 @fierro7676
RT @GantosJ: $APTO No we are at the higher doses we are going after classic-CLL patients The same concept as $ARQL they had to go to a high…
September 22nd 2020, 3:09pm
fierro7676 @fierro7676
RT @GantosJ: $APTO CEO at Opco, $ARQL drug had some FLT3 activity but not enough to get into #AML patients trial, while CG-806 is an active…
September 22nd 2020, 2:09pm
GantosJ @GantosJ
$APTO No we are at the higher doses we are going after classic-CLL patients The same concept as $ARQL they had to g… https://t.co/DuQOsngs9S
September 22nd 2020, 2:09pm
GantosJ @GantosJ
$APTO CEO at Opco, $ARQL drug had some FLT3 activity but not enough to get into #AML patients trial, while CG-806 i… https://t.co/zjYzomzSiK
September 22nd 2020, 1:09pm
jq1234t @jq1234t
@menosave @Varro_Analytics Ok, two of you say $ARQL didn’t have big followings on Twitter. Maybe my memory was dist… https://t.co/3dFQrT4vKJ
September 21st 2020, 5:09pm
gmt9992 @gmt9992
@gcbioinv @AndyBiotech is definitely one of the most knowledgeable people on Twitter and a must follow, not only because of $ARQL
September 13th 2020, 5:09pm
GantosJ @GantosJ
@mikegoodma @SalmanHussa01 Looks like doses ?600mg might end up as clinically active if we look at $ARQL's study th… https://t.co/Lw4qwfrl3b
September 4th 2020, 12:09pm
nolastevedore @nolastevedore
@DayDaySwat Arqule. $ARQL “The final phase 1 data set confirms the potential utility of ARQ 531 for the treatment o… https://t.co/brZPyHW17a
September 2nd 2020, 3:09pm
Gambiste1 @Gambiste1
RT @SubBasepair_Res: $ARQL was bought for 2.7b with the lead asset being the non-covalent BTK inhibitor ARQ-531, which generated ~60% ORR i…
August 26th 2020, 6:08pm
portefeuillefun @portefeuillefun
RT @gcbioinv: $MORF is a particularly interesting and mostly ignored company, lots of similarities to current COO/CFO former co $ARQL, crea…
August 25th 2020, 8:08am
pclark887 @pclark887
they don't expect to see the toxicities associated with $arql drug and ibrutinib $apto https://t.co/RNx5hOt6aW
August 13th 2020, 2:08pm
GantosJ @GantosJ
Good rational behind comparing $APTO to $ARQL drug hitting the #BTK & dose escalation... Investors have to underst… https://t.co/iyU37vul1i
August 13th 2020, 2:08pm
JNap5C0 @JNap5C0
RT @JNap5C: Subs - See new report on $ARQL just posted to the Coverage & Chat boards.
August 12th 2020, 8:08am
StockTipRobot @StockTipRobot
Real advice is for premium followers only... pass on ArQule $ARQL #Advice
August 11th 2020, 6:08pm
SubBasepair_Res @SubBasepair_Res
Sorry, looks like $ARQL got 8/9 responses at MTD specifically for r/r CLL pts w/ BTK C481S. $APTO edge might be CG-… https://t.co/NPOPWekbbV
August 10th 2020, 5:08pm
SubBasepair_Res @SubBasepair_Res
$ARQL was bought for 2.7b with the lead asset being the non-covalent BTK inhibitor ARQ-531, which generated ~60% OR… https://t.co/MJgHfLvzgD
August 10th 2020, 4:08pm
FlyOnTheWallHQ @FlyOnTheWallHQ
RT @FlyOnTheWallHQ: Stuck In A Rut_BB&T Corporation $BBT Confirmation Of New Non Toxic Shareholder Friendly Line Of Credit For ARQULE $ARQL…
August 6th 2020, 11:08am
jayoptionwiz @jayoptionwiz
RT @semodough: $APTO - attracted to it because done so well on $ARQL - targeted therapy tends to move fast - like everyone else just being…
August 1st 2020, 10:08pm
semodough @semodough
$APTO - attracted to it because done so well on $ARQL - targeted therapy tends to move fast - like everyone else ju… https://t.co/X7R9KexOiT
August 1st 2020, 12:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.